Prudential plc’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.71M | Hold |
27,268
| – | – | 0.01% | 414 |
|
|
2025
Q4 | $2.6M | Hold |
27,268
| – | – | 0.02% | 368 |
|
|
2025
Q3 | $2.66M | Sell |
27,268
-22,628
| -45% | -$2.34M | 0.02% | 358 |
|
|
2025
Q2 | $5.36M | Sell |
49,896
-1,720
| -3% | -$174K | 0.03% | 271 |
|
|
2025
Q1 | $5.21M | Buy |
51,616
+2,221
| +4% | +$224K | 0.03% | 269 |
|
|
2024
Q4 | $4.41M | Buy |
49,395
+11,911
| +32% | +$1.05M | 0.02% | 266 |
|
|
2024
Q3 | $3.14M | Buy |
37,484
+2,799
| +8% | +$221K | 0.02% | 337 |
|
|
2024
Q2 | $2.67M | Buy |
34,685
+2,209
| +7% | +$162K | 0.02% | 350 |
|
|
2024
Q1 | $2.22M | Sell |
32,476
-35,307
| -52% | -$2.27M | 0.02% | 389 |
|
|
2023
Q4 | $3.92M | Buy |
67,783
+13,414
| +25% | +$716K | 0.04% | 290 |
|
|
2023
Q3 | $2.87M | Sell |
54,369
-6,166
| -10% | -$323K | 0.03% | 311 |
|
|
2023
Q2 | $3.27M | Buy |
60,535
+2,624
| +5% | +$137K | 0.04% | 288 |
|
|
2023
Q1 | $2.9M | Sell |
57,911
-3,123
| -5% | -$147K | 0.03% | 296 |
|
|
2022
Q4 | $2.82M | Buy |
61,034
+32,772
| +116% | +$1.42M | 0.04% | 298 |
|
|
2022
Q3 | $1.09M | Buy |
28,262
+3,149
| +13% | +$126K | 0.02% | 384 |
|
|
2022
Q2 | $936K | Buy |
25,113
+818
| +3% | +$33.3K | 0.02% | 418 |
|
|
2022
Q1 | $1.08M | Buy |
+24,295
| New | +$1.05M | 0.02% | 421 |
|
|
2021
Q4 | – | Sell |
-42,648
| Closed | -$1.85M | – | 492 |
|
|
2021
Q3 | $1.85M | Buy |
+42,648
| New | +$1.89M | 0.03% | 239 |
|
|
2019
Q4 | – | Sell |
-7,661
| Closed | -$314K | – | 589 |
|
|
2019
Q3 | $314K | Sell |
7,661
-718
| -9% | -$30.4K | ﹤0.01% | 685 |
|
|
2019
Q2 | $360K | Hold |
8,379
| – | – | ﹤0.01% | 633 |
|
|
2019
Q1 | $322K | Hold |
8,379
| – | – | ﹤0.01% | 574 |
|
|
2018
Q4 | $296K | Sell |
8,379
-1,194
| -12% | -$43.3K | ﹤0.01% | 591 |
|
|
2018
Q3 | $369K | Hold |
9,573
| – | – | ﹤0.01% | 592 |
|
|
2018
Q2 | $313K | Hold |
9,573
| – | – | ﹤0.01% | 632 |
|
|
2018
Q1 | $262K | Sell |
9,573
-1,253
| -12% | -$34.1K | ﹤0.01% | 653 |
|
|
2017
Q4 | $268K | Buy |
10,826
+1,704
| +19% | +$47K | ﹤0.01% | 649 |
|
|
2017
Q3 | $266K | Buy |
9,122
+396
| +5% | +$10.9K | ﹤0.01% | 621 |
|
|
2017
Q2 | $242K | Hold |
8,726
| – | – | ﹤0.01% | 644 |
|
|
2017
Q1 | $217K | Buy |
+8,726
| New | +$212K | ﹤0.01% | 632 |
|
|
2014
Q1 | – | Sell |
-13,887
| Closed | -$167K | – | 498 |
|
|
2013
Q4 | $167K | Hold |
13,887
| – | – | ﹤0.01% | 482 |
|
|
2013
Q3 | $163K | Hold |
13,887
| – | – | ﹤0.01% | 461 |
|
|
2013
Q2 | $129K | Buy |
+13,887
| New | +$118K | ﹤0.01% | 418 |
|
Other funds holding BSX
VCM
VPM
Prudential plc's BSX Position: Q1 2026 in Review
Prudential plc held its Boston Scientific (BSX) position steady in Q1 2026 at 27,268 shares worth $1.71M. The position accounts for 0.01% of the portfolio, ranked #414.
Prudential plc first reported a position in BSX in Q2 2013 and has held it in 32 quarters since. The position peaked at $5.36M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Prudential plc held 27,268 shares of Boston Scientific worth $1.71M as of Q1 2026.
- Prudential plc left its Boston Scientific share count unchanged in Q1 2026.
- Boston Scientific made up 0.01% of Prudential plc's portfolio in Q1 2026, its #414 holding.
- Prudential plc first reported a position in Boston Scientific in Q2 2013 and has held it in 32 quarters since.
- Prudential plc's Boston Scientific position peaked at $5.36M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.